Hvistendahl MK, Naimi RM, Hansen SH, Rehfeld JF, et al. Bile acid-farnesoid X receptor-fibroblast growth factor 19 axis in patients with short bowel syndrome: The randomized, glepaglutide phase 2 trial. JPEN J Parenter Enteral Nutr 2022;46:923-935.
PMID: 34287979